We are changing the status quo to make the impossible possible, by expanding the scope of new targets for drug development through targeted protein manipulation.


Our science and technology are rooted in our deep and extensive knowledge of neuroscience and proteome informatics. By combining these with our computational strategies, we have developed two innovative platform technologies that enable us to design therapeutic interventions by manipulating how proteins interact and are degraded in ways that are not amenable using small molecules and antibodies.

Through our novel discovery programs, we identify key domains of disease related proteins, and design lead compounds that offer new therapeutic approaches by:


Protein-Protein Interference Blockade ] CHAPTAC ] Intellectual Property ] Scientific Publications ]